Back to search resultsSummaryRMgm-927
|
||||||||
*RMgm-927| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Introduction of a transgene |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 23897612 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Kimura, K.; Yui, K. |
| Name Group/Department | Division of Immunology, Department of Molecular Microbiology and Immunology |
| Name Institute | Nagasaki University |
| City | Nagasaki |
| Country | Japan |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-927 |
| Principal name | PbA-hsOVA; PbA-gfpOVA |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | PbA-gfpOVA expressed in the parasitophorous vacuole (membrane) of blood stages. |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | PbA-gfpOVA expressed expressed in the cytoplasm of sporozoites. |
| Liver stage | PbA-gfpOVA expressed in the parasitophorous vacuole (membrane) of liver stages. |
| Additional remarks phenotype | Mutant/mutation These mutants have been generated as described for mutant RMgm-281 but no details are provided for the promoter used to drive transgene expression, selectable marker, insertion locus etc. Other mutants
|
Transgene: Mutant parasite expressing a transgene| top of page | |||||||||||||||||||
| Type and details of transgene | |||||||||||||||||||
| Is the transgene Plasmodium derived | Transgene: not Plasmodium | ||||||||||||||||||
| Transgene name | ovalbumin (OVA) epitopes | ||||||||||||||||||
| top of page | |||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||
| Type of plasmid/construct | Plasmid double cross-over | ||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||
| Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||
| Promoter of the selectable marker | pbdhfr | ||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||
| Additional remarks genetic modification | Two mutants have been generated and analysed that express OVA: 1) PbA-hsOVA expresses a recombinant fusion protein containing the N-terminal sequence (aa 1–5) of P. berghei hsp70, an OVA323-339 MHC II epitope, a truncated sequence (aa 201–398) of P. yoelii hsp70, and an OVA257-264 MHC I epitope. 2) PbA-gfpOVA express a protein containing an OVA257-264 MHC I epitope fused to the C-terminus of GFP These mutants have been generated as described for mutant RMgm-281 but no details are provided for the promoter used to drive transgene expression, selectable marker, insertion locus etc. | ||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||
| top of page | |||||||||||||||||||
| Other details transgene | |||||||||||||||||||
| top of page | |||||||||||||||||||
| Promoter | |||||||||||||||||||
| Gene Model of Parasite | Not available | ||||||||||||||||||
| Gene Model P. falciparum ortholog | Not available | ||||||||||||||||||
| Gene product | Not available | ||||||||||||||||||
| Gene product: Alternative name | |||||||||||||||||||
| |||||||||||||||||||
| top of page | |||||||||||||||||||
| 3'-UTR | |||||||||||||||||||
| Gene Model of Parasite | Not available | ||||||||||||||||||
| Gene product | Not available | ||||||||||||||||||
| Gene product: Alternative name | |||||||||||||||||||
| |||||||||||||||||||
| Insertion/Replacement locus | |||||||||||||||||||
| Replacement / Insertion | Not available | ||||||||||||||||||
| Gene Model of Parasite | Not available | ||||||||||||||||||
| Gene product | Not available | ||||||||||||||||||
| Gene product: Alternative name | |||||||||||||||||||
| |||||||||||||||||||
| top of page | |||||||||||||||||||